System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Francesco Izzo is an expert in Oncology at Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" (Italy). As of October 2026, ScienceLeadR ranks Francesco Izzo in the top 1% of experts worldwide for Carcinoma. Francesco Izzo has authored 404 publications, the most recent in 2026, and is an investigator in 12 clinical trials, 5 of them ongoing. SLR score: 1,140 (community average: 125). How the SLR is computed.

LeadR Profile

Francesco Izzo Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Italy
1 140 ScienceLeadR Reputation 1140

Unlock

Register Login
Network Map

Oncology

Subspecialties: Surgery - Medical Imaging - Gastroenterology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2006 - 2026
Source: PubMed

Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 404

Citations

Citations: 12 273 1st author: 26 Last author: 55 Unique author: 2

Main journals

Infect Agent Cancer 24
Cancers (Basel) 16
Updates Surg 16
Ann Surg Oncol 10
J Clin Oncol 10

Best Journals

Lancet Oncol 2
J Clin Oncol 1
Lancet 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Tumor Biology and Surgical Margin Patterns in Colorectal Liver Metastases: Association Between KRAS/BRAF Status and Type of Resection Margin-BRAF-KRAS LiverMet Collaborative Group.
PMID 42864778 — margins of excision, neoplasms, liver, tumor burden, neoplasm metastasis		J Laparoendosc Adv Surg Tech A20260
Bipolar needle electrodes for electroporation-based treatments in soft and bone tissues: technical design and implementation.
PMID 42804145 — electrodes, radiology, therapeutics, tissues, electroporation, needles		Radiol Med20260
PIK3CA in Cancer: Structure, Biology, Alterations, and Actionability.
PMID 42738319 — genomics, neoplasms, therapeutics		Cancers (Basel)20260
The unusual first sign of presentation of hepatocellular carcinoma: a rare case report.
PMID 42718515 — radiotherapy, epistaxis, carcinoma, hepatocellular, neoplasms, liver, neoplasm metastasis, therapeutics, sphenoid sinus		Front Oncol20260
Robotic versus laparoscopic liver resection for intrahepatic cholangiocarcinoma in elderly patients: a multicentre propensity-weighted analysis.
PMID 42557486 — mortality, conversion to open surgery, liver, aged, endoscopy, morbidity, postoperative complications, cholangiocarcinoma, intrahepatic cholangiocarcinoma		Surg Endosc20261

Clinical Studies 12

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 6
Phase 2 4
Phase 1/Phase 2 1
Phase 3 1

By status:

Recruiting 5
Completed 3
Unknown 2
Active not recruiting 1
Withdrawn 1

By type:

Interventional 7
Observational 5

By Monocentric/Multicentric:

monocentric 9
multicentric2to4 0
multicentric5to9 3
multicentricup10 0

Main Topics

Cohort/Consortium Investigators 14

Ongoing Clinical Trials

5 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Prospective phase IIb study to evaluate the efficacy of laparoscopic electrochemotherapy in the treatment of locally advanced pancreatic cancer ECT LAPC Laparoscopic
2024-519067-17-00 — pancreatic neoplasms, neoplasms, electrochemotherapy, therapeutics		Phase 2Recruiting2024
Global Evaluation of Cholecystectomy Knowledge and Outcomes
NCT06223061 — bile, gallstones, gallbladder, emergencies, bile ducts, neoplasms, cholecystectomy, gallbladder neoplasms		N/AActive not recruiting2023
Neo adjuvant Chemo and Immunotherapy in the Pre operAtive Treatment of Locally Advanced CholangIOcarciNoma
NCT06341764 — antibodies, immunotherapy, antibodies, monoclonal, therapeutics, cholangiocarcinoma		Phase 2Recruiting2023
Prediction of True Oligo metastatic Disease
NCT05806151 — radiotherapy, lymphocytes, neoplasms, gastrointestinal tract, neoplasm metastasis, radiofrequency ablation, therapeutics, colorectal neoplasms, tissues, t-lymphocytes		N/ARecruiting2023
Unravelling the Impact of Radiofrecuency in Liver Surgery the Key to Decrease Local Recurrence
NCT05492136 — margins of excision, neoplasms, liver, hepatectomy, liver neoplasms, neoplasms, second primary, therapeutics, ischemia		N/ARecruiting2023

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS